Effect of batroxobin on spontaneous echo contrast and hemorheology in left atrial appendage in atrial fibrillation assessed by transesophageal echocardiography

American Journal of Cardiology

Volumn 84, Issue 7, 1999, Pages 816-819

  Sakamoto, Seiji ^a   Mizushige, Katsufumi ^a   Takagi, Yuichiro ^a   Ueda, Takashi ^a   Ohmori, Koji ^a   Matsuo, Hirohide ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BATROXOBIN; FIBRINOGEN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD VISCOSITY; CELL AGGREGATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ECHOCARDIOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FIBRINOGEN BLOOD LEVEL; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART HEMODYNAMICS; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THROMBOSIS PREVENTION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

AGED; ANALYSIS OF VARIANCE; ATRIAL FIBRILLATION; BATROXOBIN; BLOOD FLOW VELOCITY; BLOOD VISCOSITY; CHI-SQUARE DISTRIBUTION; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; FEMALE; FIBRINOLYTIC AGENTS; HEMORHEOLOGY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; REGRESSION ANALYSIS;

EID: 0032885745     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(99)00443-9     Document Type: Article

References (21)

1. Lip G.Y.H., Lowe G.D.O., Rumley A., Dunn F.G. Increased markers of thrombogenesis in chronic atrial fibrillation effects of warfarin treatment . Br Heart J. 73:1995;527-533.
2. Lip G.Y.H., Lowe G.D.O., Rumley A., Dunn F.G. Fibrinogen and fibrin D-dimer levels in paroxysmal atrial fibrillation evidence for intermediate elevated levels of intravascular thrombogenesis . Am Heart J. 131:1996;724-730.
3. Kahn S.R., Solymoss S., Flegel K.M. Nonvalvular atrial fibrillation evidence for a prothrombotic state . Can Med Assoc J. 157:1997;673-681.
4. Gustafsson C., Blomback M., Britton M., Hamsten A., Svensson J. Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke. 21:1990;47-51.
5. Black I.W., Chesterman C.N., Hopkins A.P., Lee L.C.L., Chong B.H., Walsh W.F. Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation. J Am Coll Cardiol. 21:1993;451-457.
6. Fatkin D., Herbert E., Feneley M.P. Hematologic correlates of spontaneous echo contrast in patients with atrial fibrillation and implications for thromboembolic risk. Am J Cardiol. 73:1994;672-676.
7. Daniel W.G., Nellessen U., Schröder E., Nonnast-Daniel B., Bednarski P., Nikutta P., Lichtlen P.R. Left atrial spontaneous echo contrast in mitral valve disease an indicator for increased thromboembolic risk . J Am Coll Cardiol. 11:1988;1204-1211.
8. Beppu S., Nimura Y., Sakakibara H., Nagata S., Park Y.D., Izumi S., Ueoka M., Masuda Y., Nakasone I. Smoke-like echo in the left atrial cavity in mitral valve disease its features and significance . J Am Coll Cardiol. 6:1985;744-749.
9. Castello R., Pearson A.C., Labovitz A.J., Lenzen P. Prevalence and clinical implications of atrial spontaneous contrast in patients undergoing transesophageal echocardiography. Am J Cardiol. 65:1990;1149-1153.
10. Belder M.A., Lovat L.B., Tourikis L., Leech G., Camm A. Left atrial spontaneous contrast echoes-markers of thromboembolic risk in patients with atrial fibrillation. Eur Heart J. 14:1993;326-335.
11. Briley D.P., Giraud G.D., Beamer N.B., Spear E.M., Grauer S.E., Edwards J.M., Clark W.M., Sexton G.J., Coull B.M. Spontaneous echo contrast and hemorheologic abnormalities in cerebrovascular disease. Stroke. 25:1994;1564-1569.
12. Stocker K., Barlow G.H. The coagulant enzyme from Bothrops atrox venom (batroxobin). Lornand L. Methods in Emzymology. 45:1976;214-223 Academic Press, New York-San Francisco-London.
13. Fukutake K., Fujimaki M., Nagasawa H., Kato M. Clinicpharmacological observations of batroxobin (Defibrase®) administered to normal human adults. Acta Haematol Jpn. 44:1981;1178-1194.
14. Blättler W., Straub P.W., Peyer A. Effect of in vivo produced fibrinogen-fibrin intermediates on viscosity of human blood. Thromb Res. 4:1974;213-218.
15. Fatkin D., Kelly R.P., Feneley M.P. Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol. 23:1994;961-969.
16. Klein A.L., Murray D., Black I.W., Chandra S., Grimm R.A., D'sa A.P., Leung D.Y.C., Miller D., Morehead A.J., Vaughn S.E., Thomas J.D. Integrated backscatter for quantification of left atrial spontaneous echo contrast. J Am Coll Cardiol. 28:1996;222-231.
17. Yasunaga K., Kamada K., Matsuda K. Coagulation studies on the patients treated with defibrase, a snake venom batroxobin. Jpn Arch Intern Med. 26:1979;465-474.
18. Black I.W., Hopkins A.P., Lee L.C.L., Walsh W.F., Jacobson B.M. Left atrial spontaneous echo contrast a clinical and echocardiographic analysis . J Am Coll Cardiol. 18:1991;398-404.
19. Chimowitz M.I., DeGeorgia M.A., Poole R.M., Hepner A., Armstrong W.M. Left atrial spontaneous echo contrast is highly associated with previous stroke in patients with atrial fibrillation or mitral stenosis. Stroke. 24:1993;1015-1019.
20. Albers G.W., Comess K.A., DeRook F.A., Atwood J.E., Bolger A., Hotson J. Transesophageal echocardiographic findings in stroke subtypes. Stroke. 25:1994;23-28.
21. Tsai L.M., Chen J.H., Lin L.J., Teng J.K. Natural history of left atrial spontaneous echo contrast in nonrheumatic atrial fibrillation. Am J Cardiol. 80:1997;897-900.